Federated Hermes, Inc. 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-10 08:47 am Sale |
2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
FEDERATED HERMES INC. FHI |
3,094,500 4.410% |
-892,370 (-22.38%) |
Filing |
| 2022-02-14 3:02 pm Sale |
2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
FEDERATED HERMES INC. FHI |
3,986,870 5.850% |
-293,658 (-6.86%) |
Filing |
| 2021-02-12 1:06 pm Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
FEDERATED HERMES INC. FHI |
4,280,528 6.470% |
1,308,520 (+44.03%) |
Filing |